CVCT-ME Program is accredited for 12 CME Hours by United Arab Emirates University UAEU

Welcome to the First Edition of CVCT Middle East Website

Dear Colleagues
Over the last 10 years, the Global CardioVascular Clinical Trialists Forum has aimed to provide a platform for engaging stakeholders to evaluate current and future clinical trial designs in cardiovascular medicine therapeutics (both pharma and devices), actively involving major principal investigators, trialists, industry R&D, regulators (FDA, EMA, PMDA), institutions (NHLBI, EU, H2020, Inserm), journal editors (NEJM, The Lancet, Circulation, JACC, EHJ), learned societies (ACC, ESC, HFSA, ASN, EACPT, ISCP), analysts, CROs, payers, practitioners, patients and citizens.All stakeholders are invested in these important discussions. Regulators are keen to learn from academy and industry experts are eager to find out the right answer in order to address the unmet clinical needsand also to satisfy the regulators. This year, for the first time, CVCT is held in Abu Dhabi, Emirates. The CVCT Middle East Forum brings together for the first time top Middle East and African cardiovascular trialists, investigators, statisticians, industry R&D experts, national regulators and practitioners across the region. The contribution of this region to global CV trials and clinical research is to increase significantly in collaboration with Gulf Heart AssociationRead More

Course directors

Pr Faiez ZANNAD, MD. PhD

Professor of Therapeutics and Cardiology
INSERM Clinical Investigation Centre
Institut Lorrain du Coeur et des Vaisseaux
CHU and University of Lorraine

Nancy, France
Dr Wael Al-Mahmeed, MD

Division Chief – Medical Affairs
Sheikh Khalifa Medical City, Abu Dhabi
President of Gulf Heart Association

United Arab Emirates